TG Therapeutics Inc.

TGTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$57.16

+$0.29 (+0.51%)

At close: Sep 21, 2026, 4:00 PM ET

$57.44

+$0.28 (+0.49%)

Pre-market: Sep 22, 2026, 8:16 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	447.18M	23.38M	12.67M	-198.34M	-348.1M	-279.38M
Depreciation & Amortization	59K	280K	423K	515K	494K	374K
Stock-Based Compensation	64.67M	42.54M	37.93M	19.19M	61.27M	80.29M
Other Working Capital	-40.52M	35.65M	3.18M	7.97M	-10.83M	-31.39M
Other Non-Cash Items	5.86M	2.58M	2.22M	4.11M	2.4M	4M
Deferred Income Tax	-348M	n/a	n/a	n/a	517K	-30K
Change in Working Capital	-194.54M	-109.3M	-84.66M	-1.65M	-12.22M	-19.76M
Operating Cash Flow	-24.77M	-40.52M	-31.41M	-176.17M	-295.63M	-214.51M
Capital Expenditures	-214K	-45K	n/a	-14K	-401K	-357K
Cash Acquisitions	n/a	n/a	n/a	20M	-69K	24.15M
Purchase of Investments	-223.49M	-311.89M	-146.88M	-107.27M	-55.53M	-67.4M
Sales Maturities Of Investments	237.5M	310.9M	96.23M	87.28M	55.6M	43.25M
Other Investing Acitivies	n/a	n/a	n/a	-20M	69K	-24.15M
Investing Cash Flow	13.8M	-1.04M	-50.65M	-20.01M	-332K	-24.51M
Debt Repayment	n/a	137.26M	25M	-975K	40M	n/a
Common Stock Repurchased	-91.24M	-8.76M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	25K	1.41M	n/a	-800K	147K
Financial Cash Flow	-89.73M	128.53M	72.71M	-391K	41.42M	679.83M
Net Cash Flow	-100.7M	86.97M	-9.36M	-196.57M	-254.55M	440.81M
Free Cash Flow	-24.99M	-40.56M	-31.41M	-176.18M	-296.04M	-214.86M
Adj. Free Cash Flow	-89.66M	-83.1M	-69.35M	-195.37M	-357.31M	-295.15M
Maintenance CapEx	n/a	n/a	n/a	-14K	n/a	-357K
Growth CapEx	-214K	-45K	n/a	n/a	-401K	n/a
Owner Earnings	-24.77M	-40.52M	-31.41M	-176.18M	-295.63M	-214.86M